{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:21:26Z","timestamp":1777929686832,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugalcdep.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T13:54:52Z","timestamp":1496238892000},"page":"101-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids"],"prefix":"10.1016","volume":"177","author":[{"given":"Theodore J.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary A.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0005","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam rablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.annemergmed.2016.06.014","article-title":"Fentanyl and a novel synthetic opioid U-47700 masquerading as street Norco in Central California. A case report","volume":"69","author":"Armenian","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0015","series-title":"CDC Health Advisory: Increases in Fentanyl Drug Confiscations and Fentanyl-Related Overdose Fatalities","author":"Centers for Disease Control","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.forsciint.2016.05.001","article-title":"A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700)","volume":"266","author":"Coopman","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0025","series-title":"DEA Issues Nationwide Alert on Fentanyl as Threat to Health and Public Safety","author":"Drug Enforcement Administration","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0030","series-title":"National Heroin Threat Assessment Summary","author":"Drug Enforcement Administration","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Supplement to trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions andincreases in synthetic opioid\u2013involved overdose deaths\u201427 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0050","series-title":"Use of Synthetic Opioid U-47700 Poses Risk to Kansas Citizens","author":"Kansas Bureau of Investigation","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","article-title":"Novel synthetic opioids: an opioid epidemic within an opioid epidemic","volume":"69","author":"Lucyk","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2017.04.004_bib0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.15585\/mmwr.mm6533a3","article-title":"Increases in fentanyl-related overdose deaths \u2013 florida and ohio, 2013\u20132015","volume":"65","author":"Peterson","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T14:52:05Z","timestamp":1536245525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617302338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":12,"alternative-id":["S0376871617302338"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.04.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}